Ergoteles’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-32,636
| Closed | -$4.76M | – | 1517 |
|
|
2022
Q2 | $4.76M | Buy |
+32,636
| New | +$4.76M | 0.14% | 158 |
|
|
2021
Q3 | – | Sell |
-8,811
| Closed | -$1.49M | – | 1164 |
|
|
2021
Q2 | $1.49M | Buy |
+8,811
| New | +$1.49M | 0.03% | 413 |
|
|
2020
Q4 | – | Sell |
-25,661
| Closed | -$3.74M | – | 653 |
|
|
2020
Q3 | $3.74M | Buy |
+25,661
| New | +$3.74M | 0.49% | 38 |
|